Recent 8-K filings for ZBIO

Each filing is summarized by an LLM — headline, three bullets, event type. The source document on EDGAR is one click away. See methodology.

• May 13, 2026 10:14 UTC earnings item 2.02item 5.02item 5.07item 9.01

  Zenas BioPharma Q1 net loss $81M; obexelimab BLA on track

source · ZBIO on sec.gov